MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 7,562 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 818,295 shares of the medical equipment provider's stock after selling 7,562 shares during the quarter. Intuitive Surgical comprises 0.9% of MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s portfolio, making the stock its 12th biggest holding. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.23% of Intuitive Surgical worth $427,142,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Czech National Bank lifted its stake in shares of Intuitive Surgical by 6.9% during the 4th quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider's stock worth $40,309,000 after acquiring an additional 4,970 shares during the last quarter. Fiduciary Alliance LLC lifted its stake in shares of Intuitive Surgical by 33.7% during the 4th quarter. Fiduciary Alliance LLC now owns 12,497 shares of the medical equipment provider's stock worth $6,523,000 after acquiring an additional 3,151 shares during the last quarter. Brookstone Capital Management lifted its stake in shares of Intuitive Surgical by 25.4% during the 4th quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider's stock worth $9,448,000 after acquiring an additional 3,663 shares during the last quarter. Capital Investment Advisors LLC lifted its stake in shares of Intuitive Surgical by 15.6% during the 4th quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider's stock worth $469,000 after acquiring an additional 121 shares during the last quarter. Finally, Kieckhefer Group LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $5,632,000. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of research analyst reports. Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Barclays decreased their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. Royal Bank of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $598.95.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company's stock, valued at approximately $205,093. The trade was a 87.18% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares of the company's stock, valued at $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,700 shares of company stock worth $16,865,621. 0.70% of the stock is owned by insiders.

Intuitive Surgical Trading Up 0.6%

NASDAQ ISRG traded up $3.32 during trading hours on Friday, reaching $563.60. The company's stock had a trading volume of 1,422,176 shares, compared to its average volume of 1,640,855. The business has a 50-day simple moving average of $505.22 and a 200 day simple moving average of $536.45. Intuitive Surgical, Inc. has a 52 week low of $393.98 and a 52 week high of $616.00. The stock has a market cap of $202.00 billion, a PE ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the business earned $1.50 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.